corporate funder

Alkermes

www.alkermes.com (opens in a new tab)2 openCatalog updated

Open programs2

  1. Alkermes Investigator Sponsored Studies Program

    Alkermes’ Investigator Sponsored Studies (ISS) program supports independent U.S.-based clinical and scientific research aligned with its areas of interest, including sleep disorders, schizophrenia, bipolar I disorder, and aripiprazole lauroxil.

    Research ProjectHealth

    Deadline
    Not listed
    Amount
    $300,000

  2. Alkermes Pathways Research Awards — Early-Career Neuroscience Research Grants (Schizophrenia & Bipolar I Disorder)

    Alkermes offers the Pathways Research Awards, funding individual early-career investigators up to $100,000 for preclinical, clinical, translational, epidemiological and outcomes research focused on schizophrenia or bipolar I disorder, with a 2025 emphasis on sleep and circadian disturbances.

    Research ProjectNeuroscience

    Deadline
    Not listed
    Amount
    $100,000

Program details are the catalog's own fields as FundFit holds them: title, category, deadline, and amount. For the full listing and eligibility, follow the funder's site.

Same type

More corporate funders

See FundFit match these programs to your researchers.

Request a demo

Or browse every funder in the directory →